title: Botulinum toxin: A lift for chronic migraines.
abstract: Chronic migraines are a common condition among patients seen in primary care and management often is a challenge. Despite existing therapies to help manage this condition, many patients continue to experience undue stress and diminished quality of life secondary to pain. This article briefly reviews treatments for migraine and introduces the role of onabotulinumtoxin A (Botox A) in improving the management of chronic migraines.
authors.affiliation: Lorraine A. Sanassi practices emergency medicine at New York Presbyterian Queens in Flushing, N.Y., and is an assistant professor at SUNY Downstate Medical Center in Brooklyn, N.Y. The author has disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Lorraine A
authors.initials: LA
authors.lastname: Sanassi
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010146:Pain; D011788:Quality of Life
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A